Abstract
Disruption of tight cell adhesion mediated by E-cadherin is an important step in carcinoma progression for cells to initiate cell migration and progress to metastasize. During prostate cacinogenesis, E-cadherin gene expression or function is downregulated through multiple mechanisms, many of which combine to silence E-cadherin expression through transcriptional regulation at the level of the E-cadherin promoter. Recent evidence indicates that concomitant with the transcriptional silencing of E-cadherin in prostate carcinomas, there is transcriptional upregulation of the mesenchymal cadherin, N-cadherin. The mechanisms of E- to N-cadherin switching in carcinomas and Key the potential roles of N-cadherin in tumor metastasis are summarized.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
REFERENCES
Nagle, R.B., Knox, J.D., Wolf, C., Bowden, G.T., and Cress, A.E., 1994, Adhesion molecules, extracellular matrix, and proteases in prostate carcinoma. J. Cellular Biochem. 19: 232–237.
Ross, J.S., Figge, H.L., Bui, H.X., del Rosario, A.D., Fisher, H.A., Nazeer, T.X., Ingle, R., and Kim, D.N., 1994, E-cadherin expression in prostatic carcinoma biopsies: correlation with tumor grade, DNA content, pathologic stage, and clinical outcome. Modern Pathology 7: 835–841.
Schipper, J.H., Frixen, U.H., Behrens, J., Unger, A., Jahnke, K., and Birchmeier, W., 1991, E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res. 51: 6328–6337.
Moll, R., Mitze, M., Frixen, U.H., and Birchmeier, W., 1993, Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am. J. Pathol. 143: 1731–1742.
Behrens, J., Mareel, M.M., Van Roy, F.M., and Birchmeier, W., 1989, Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell- cell adhesion. J. Cell Biol. 108: 2435–2447.
Nagafuchi, A., Takeichi, M., 1988, Cell binding function of E-cadherin is regulated by the cytoplasmic domain. EMBO J. 7: 3679–3684.
Umbas, R., Schalken, J.A., Aalders, T.W., Carter, B.S., Karthaus, H.F., Schaafsma, H.E., and Isaacs, W.B., 1992, Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res. 52: 5104–5109.
Umbas, R., Isaacs, W.B., Bringuier, P.P. , Schaafsma, H.E., Karthaus, H.F., Oosterhof, G.O., Debruyne, F.M., and Schalken, J.A., 1994, Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res. 54: 3929–3933.
Kuczyk, M., Serth, J., Machtens, S., Bokemeyer, C., Bathke, W., Stief, C., and Jonas, U., 1998, Expression of E-cadherin in primary prostate cancer: correlation with clinical features. Br. J. Urol. 81: 406–412.
Dhanasekaran, S.M., Barrette, T.R., Ghosh, D., Shah, R., Varambally, S., Kurachi, K., Pienta, K.J., Rubin, M.A., and Chinnaiyan, A.M., 2001, Delineation of prognostic biomarkers in prostate cancer. Nature 412: 822–826.
De Marzo, A.M., Knudsen, B., Chan-Tack, K., and Epstein, J.I., 1999, E-cadherin expression as a marker of tumor aggressiveness in routinely processed radical prostatectomy specimens, Urology 53: 707–713.
Berx, G., Staes, K., van Hengel, J., Molemans, F., Bussemakes, MJ., van Bokhoven, A., and Van Roy, F., 1995 Cloning and characterization of the human invasion suppressor gene E-cadherin (CDH1). Genomics 26: 281–289.
Graff, J.R., Gabrielson, E., Fujii, H., Baylin, S.B., and Herman, J.G., 2000, Methylation patterns of the E-cadherin 5’ CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression. J. Biol. Chem. 275: 2727–2732.
Graff, J.R., Herman, J.G., Lapidus, R.G., Chopra, H., Xu, R., Jarrard, D.F. X.I. W., Pitha, P.M., Davidson, N.E., and Baylin, S.B., 1995, E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res. 55: 5195–5199.
Li, L.C., Zhao, H., Nakajima, K., Oh, B.R., Ribeiro Filho, L.A., Carroll, P. , and Dahiya, R., 2001, Methylation of the E-cadherin gene promoter correlates with progression of prostate cancer. J. Urol. 166: 705–709.
Kallakury, B.V., Sheehan, C.E., Winn-Deen, E., Oliver, J., Fisher, H.A., Kaufman, R.P. , Jr., and Ross, J.S., 2001, Decreased expression of catenins (alpha and beta), p120 CTN, and E-cadherin cell adhesion proteins and E-cadherin gene promoter methylation in prostatic adenocarcinomas. Cancer 92: 2786–2795.
Kang, G.H., Lee, S., Lee, H.J., and Hwang, K.S., 2004, Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia. J. Pathol. 202: 233–240.
Tomita, K., van Bokhoven, A., van Leenders, G.J., Ruijter, E.T., Jansen, C.F., Bussemakers, M.J., and Schalken, J.A., 2000, Cadherin switching in human prostate cancer progression. Cancer Res. 60: 3650–3654.
Bussemakers, M.J., van Bokhoven, A., Tomita, K., Jansen, C.F., and Schalken, J.A., 2000, Complex cadherin expression in human prostate cancer cells. Int. J. Cancer 85: 446–450.
Tran, N.L., Cress, A.E., Nagle, R.B., and Heimark, R.L., 1999, Expression of N-cadherin in Invasive Human Prostate Carcinomas: Transformation from an Epithelial to a Mesenchymal Phenotype. Am. J. Pathol. 155: 787–798.
Jaggi, M., Nazemi, T., Abrahams, N.A., Baker, J.J., Galich, A., Smith, L.M., and Balaji, K.C., 2005, N-cadherin switching occurs in high Gleason grade prostate cancer. Prostate.
Islam, S., Carey, T.E., Wolf, G.T., Wheelock, M.J., and Johnson, K.R., 1996, Expression of N-cadherin by human squamous carcinoma cells induces a scattered fibroblastic phenotype with disrupted cell-cell adhesion. J. of Cell Biol. 135: 1643–1654.
Hazan, R.B., Kang, L., Whooley, B.P. , and Borgen, P. I., 1997, N-cadherin promotes adhesion between invasive breast cancer cells and the stroma. Cell Adhesion & Communication 4: 399–411.
Nieman, M.T., Prudoff, R.S., Johnson, K.R., and Wheelock, M.J., 1999, N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J. Cell Biol. 147: 631–644.
Li, Y., Liu, W., Hayward, S.W., Cunha, G.R., and Baskin, L.S., 2000, Plasticity of the urothelial phenotype: effects of gastro-intestinal mesenchyme/stroma and implications for urinary tract reconstruction. Differentiation 66: 126–135.
Hazan, R.B., Phillips, G.R., Qiao, R.F., Norton, L., and Aaronson, S.A., 2000, Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J. Cell Biol. 148: 779–790.
Villers, A., McNeal, J.E., Redwine, E.A., Freiha, F.S., and Stamey, T.A., 1989, The role of perineural space invasion in the local spread of prostatic adenocarcinoma. J. Urology 142: 763–768.
Navarro, P. , Ruco, L., and Dejana, E., 1998, Differential localization of VE- and N-cadherins in human endothelial cells: VE-cadherin competes with N-cadherin for junctional localization. J. of Cell Biol. 140: 1475–1484.
Johnson, K.R., Lewis, J.E., Li, D., Wahl, J., Soler, A.P. , Knudsen, K.A., Wheelock, and M.J., 1993, P- and E-cadherin are in separate complexes in cells expressing both cadherins. Exp. Cell Res. 207: 252–260.
Chen, H., Paradies, N.E., Fedor-Chaiken, M., and Brackenbury, R., 1997, E-cadherin mediates adhesion and suppresses cell motility via distinct mechanisms. J. Cell Science 110: 345–356.
Williams, E.J., Furness, J., Walsh, F.S., and Doherty, P. , 1994, Activation of the FGF receptor underlies neurite outgrowth stimulated by L1, N-CAM, and N-cadherin. Neuron 13: 583–594.
Suyama, K., Shapiro, I., Guttman, M., and Hazan, R.B., 2002, A signaling pathway leading to metastasis is controlled by N-cadherin and the FGF receptor. Cancer Cell 2: 301–314.
Kim, J.B., Islam, S., Kim, Y.J., Prudoff, R.S., Sass, K.M., Wheelock, MJ, and Johnson, K.R., 2000, N-Cadherin extracellular repeat 4 mediates epithelial to mesenchymal transition and increased motility. J. Cell Biol. 151: 1193–1206.
Luo, Y., Radice, G.L., 2005, N-cadherin acts upstream of VE-cadherin in controlling vascular morphogenesis. J. Cell Biol. 169: 29–34.
Steinberg, M.S., Takeichi, M., 1994, Experimental specification of cell sorting, tissue spreading, and specific spatial patterning by quantitative differences in cadherin expression. Proc. Natl. Acad. Sci. USA, 91: 206–209.
Behrens, J., Lowrick, O., Klein-Hitpass, L., and Birchmeier, W., 1991, The E-cadherin promoter: functional analysis of a G.C-rich region and an epithelial cell-specific palindromic regulatory element. Proc. Natl. Acad. Sci. USA, 88: 11495–11499.
Hennig, G., Lowrick, O., Birchmeier, W., and Behrens, J., 1996, Mechanisms identified in the transcriptional control of epithelial gene expression. J. Biol. Chem. 271: 595–602.
Comijn, J., Berx, G., Vermassen, P. , Verschueren, K., van Grunsven, L., Bruyneel, E., Mareel, M., Huylebroeck, D., and Van Roy, F., 2001, The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol. Cell 7: 1267–1278.
Batlle, E., Sancho, E., Franci, C., Dominguez, D., Monfar, M., Baulida, J., and Garcia, D.H., 2000, The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nature Cell Biology 2: 84–89.
Novak, A., Hsu, S.C., Leung-Hagesteijn, C., Radeva, G., Papkoff, J., Montesano, R., Roskelley, C., Grosschedl, R., and Dedhar, S., 1998, Cell adhesion and the integrin-linked kinase regulate the LEF-1 and beta-catenin signaling pathways. Proc. Natl. Acad. Sci. USA, 95, 4374–4379.
Tan, C., Costello, P. , Sanghera, J., Dominguez, D., Baulida, J., de Herreros, A.G., and Dedhar, S., 2001, Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/- human colon carcinoma cells. Oncogene, 20 133–140.
Guaita, S., Puig, I., Franci, C., Garrido, M., Dominguez, D., Batlle, E., Sancho, E., Dedhar, S., de Herreros, A.G., and Baulida, J., 2002, Snail induction of epithelial to mesenchymal transition in tumor cells is accompanied by MUC1 repression and ZEB1 expression . J. Biol. Chem. 277: 39209–39216.
Perez-Moreno, M.A., Locascio, A., Rodrigo, I., Dhondt, G., Portillo, F., Nieto, M.A., and Cano, A., 2001, A new role for E12/E47 in the repression of E-cadherin expression and epithelial-mesenchymal transitions. J. Biol. Chem. 276: 27424–27431.
Yang, J., Mani, S.A., Donaher, J.L., Ramaswamy, S., Itzykson, R.A., Come, C., Savagner, P. , Gitelman, I., Richardson, A., and Weinberg, R.A., 2004, Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117: 927–939.
Howe, L.R., Watanabe, O., Leonard, J., and Brown, A.M., 2003, Twist is up-regulated in response to Wnt1 and inhibits mouse mammary cell differentiation. Cancer Res. 63: 1906–1913.
Oda, H., Tsukita, S., and Takeichi, M., 1998, Dynamic behavior of the cadherin-based cell-cell adhesion system during Drosophila gastrulation. Dev. Biol. 203: 435–450.
Rosivatz, E., Becker, I., Specht, K., Fricke, E., Luber, B., Busch, R., Hofler, H., and Becker, K.F., 2002, Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer. Am. J. Pathol. 161: 1881–1891.
Kwok, W.K., Ling, M.T., Lee, T.W., Lau, T.C., Zhou, C., Zhang, X., Chua, C.W., Chan, K.W., Chan, F.L., Glackin, C., Wong, Y.C., and Wang, X., 2005, Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target. Cancer Res. 65: 5153–5162.
Stasinopoulos, I.A., Mironchik, Y., Raman, A., Wildes, F., Winnard, P. , Jr., and Raman, V., 2005, HOXA5-twist interaction alters p53 homeostasis in breast cancer cells. J. Biol. Chem., 280: 2294–2299.
Hamamori, Y., Sartorelli, V., Ogryzko, V., Puri, P. L., Wu, H.Y., Wang, J.Y., Nakatani, Y., and Kedes, L., 1999, Regulation of histone acetyltransferases p300 and PCAF by the bHLH protein twist and adenoviral oncoprotein E1A. Cell 96: 405–413.
Firulli, B.A., Krawchuk, D., Centonze, V.E., Vargesson, N., Virshup, D.M., Conway, S.J., Cserjesi, P. , Laufer, E., and Firulli, A.B., 2005, Altered Twist1 and Hand2 dimerization is associated with Saethre-Chotzen syndrome and limb abnormalities. Nat. Genet. 37: 373–381.
Wallis, J., Fox, M.F., and Walsh, F.S., 1994, Structure of the human N-cadherin gene: YAC analysis and fine chromosomal mapping to 18q11.2. Genomics 22: 172–179.
Le Mee, S., Fromigue, O., and Marie, P. J., 2005, Sp1/Sp3 and the myeloid zinc finger gene MZF1 regulate the human N-cadherin promoter in osteoblasts. Exp. Cell Res. 302: 129–142.
Bowen, C., Bubendorf, L., Voeller, H.J., Slack, R., Willi, N., Sauter, G., Gasser, T.C., Koivisto, P. , Lack, E.E., Kononen, J., Kallioniemi, O.P. , and Gelmann, E.P. , 2000, Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression. Cancer Res. 60: 6111–6115.
Abdulkadir, S.A., Magee, J.A., Peters, T.J., Kaleem, Z., Naughton, C.K., Humphrey, P. A., and Milbrandt, J., 2002, Conditional loss of Nkx3.1 in adult mice induces prostatic intraepithelial neoplasia . Mol. Cell Biol. 22: 1495–1503.
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S.I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., Bigner, S.H., Giovanella, B.C., Ittmann, M., Tycko, B., Hibshoosh, H., Wigler, M.H., and Parsons, R., 1997, PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science, 275: 1943–1947.
Abate-Shen, C., Banach-Petrosky, W.A., Sun, X., Economides, K.D., Desai, N., Gregg, J.P. , Borowsky, A.D., Cardiff, R.D., and Shen, M.M., 2003, Nkx3.1; Pten mutant mice develop invasive prostate adenocarcinoma and lymph node metastases. Cancer Research.63: 3886–90.
Bachelder, R.E., Yoon, S.O., Franci, C., de Herreros, A.G., and Mercurio, A.M., 2005, Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription: implications for the epithelial-mesenchymal transition . J. Cell Biol. 168: 29–33.
Zhou, B.P. , Deng, J., Xia, W., Xu, J., Li, Y.M., Gunduz, M., and Hung, M.C., 2004, Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat. Cell Biol., 6: 931–940.
Yap, A.S., Niessen, C.M., and Gumbiner, B.M., 1998, The juxtamembrane region of the cadherin cytoplasmic tail supports lateral clustering, adhesive strengthening, and interaction with p120ctn. J. Cell Biol. 141: 779–789.
Anastasiadis, P. Z., Moon, S.Y., Thoreson, M.A., Mariner, D.J., Crawford, H.C., Zheng, Y., and Reynolds, A.B., 2000, Inhibition of RhoA by p120 catenin. Nature Cell Biology 2: 637–644.
Noren, N.K., Liu, B.P. , Burridge, K., and Kreft, B., 2000, p120 catenin regulates the actin cytoskeleton via Rho family GTPases. J. Cell Biol. 150: 567–580.
Braga, V.M., Machesky, L.M., Hall, A., and Hotchin, N.A., 1997, The small GTPases Rho and Rac are required for the establishment of cadherin-dependent cell-cell contacts. J. Cell Biol. 137: 1421–1431.
Takaishi, K., Sasaki, T., Kotani, H., Nishioka, H., and Takai, Y., 1997, Regulation of cell-cell adhesion by rac and rho small G proteins in MDCK cells. J. Cell Biol. 139: 1047–1059.
Kuroda, S., Fukata, M., Nakagawa, M., Fujii, K., Nakamura, T., Ookubo, T., Izawa, I., Nagase, T., Nomura, N., Tani, H., Shoji, I., Matsuura, Y., Yonehara, S., and Kaibuchi, K., 1998, Role of IQGAP1, a target of the small GTPases Cdc42 and Rac1, in regulation of E-cadherin- mediated cell-cell adhesion. Science 281: 832–835.
Malliri, A., van Es, S., Huveneers, S., and Collard, J.G., 2004, The Rac exchange factor Tiam 1 is required for the establishment and maintenance of cadherin-based adhesions. J. Biol. Chem. 279: 30092–30098.
Muller, T., Choidas, A., Reichmann, E., and Ullrich, A, 1999, Phosphorylation and free pool of beta-catenin are regulated by tyrosine kinases and tyrosine phosphatases during epithelial cell migration. J. Biol. Chem. 274: 10173–10183.
Rosato, R., Veltmaat, J.M., Groffen, J., and Heisterkamp, N., 1998, Involvement of the tyrosine kinase fer in cell adhesion. Molecular & Cellular Biology 18: 5762–5770.
Piedra, J., Martinez, D., Castano, J., Miravet, S., Dunach, M., and de Herreros, A.G., 2001, Regulation of beta-catenin structure and activity by tyrosine phosphorylation. J. Biol. Chem. 276: 20436–20443.
Allard, P. , Zoubeidi, A., Nguyen, L.T., Tessier, S., Tanguay, S., Chevrette, M., Aprikian, A., and Chevalier, S., 2000, Links between Fer tyrosine kinase expression levels and prostate cell proliferation. Molecular & Cellular Endocrinology 159: 63–77.
Arregui, C., Pathre, P. , Lilien, J., and Balsamo, J., 2000, The nonreceptor tyrosine kinase fer mediates cross-talk between N-cadherin and beta1-integrins. J. Cell Biol. 149: 1263–1274.
Krakstad, B.F., Ardawatia, V.V., and Aragay, A.M., 2004, A role for Galpha12/Galpha13 in p120ctn regulation. Proc. Natl. Acad. Sci. 101:10314–9.
Kaplan, D.D., Meigs, T.E., and Casey, P. J., 2001, Distinct regions of the cadherin cytoplasmic domain are essential for functional interaction with Galpha 12 and betacatenin. J. Biol. Chem. 276: 44037–44043.
Kurose, H., 2003, Galpha12 and Galpha13 as key regulatory mediator in signal transduction. Life Sci. 74: 155–161.
Yan, H.X., He, Y.Q., Dong, H., Zhang, P. , Zeng, J.Z., Cao, H.F., Wu, M.C., and Wang, H.Y., 2002, Physical and functional interaction between receptor-like protein tyrosine phosphatase PCP-2 and beta-catenin, Biochemistry 41: 15854–15860.
Ukropec, J.A., Hollinger, M.K., Salva, S.M., and Woolkalis, M.J., 2000, SHP2 association with VE-cadherin complexes in human endothelial cells is regulated by thrombin. J. Biol.Chem. 275: 5983–5986.
Holsinger, L.J., Ward, K., Duffield, B., Zachwieja, J., and Jallal, B., 2002, The transmembrane receptor protein tyrosine phosphatase DEP1 interacts with p. 120(ctn). Oncogene 21: 7067–7076.
Brady-Kalnay, S.M., Mourton, T., Nixon, J.P. , Pietz, G.E., Kinch, M., Chen, H., Brackenbury, R., Rimm, D.L., Del Vecchio, R.L., and Tonks, N.K., 1998, Dynamic interaction of PTPmu with multiple cadherins in vivo. J. of Cell Biol. 141: 287–296.
Balsamo, J., Leung, T., Ernst, H., Zanin, M.K., and Hoffman, S.X., 1996, Regulated binding of PTP1B-like phosphatase to N-cadherin: control of cadherin-mediated adhesion by dephosphorylation of beta-catenin. J. Cell Biol. 134: 801–813.
Hellberg, C.B., Burden-Gulley, S.M., Pietz, G.E., and Brady-Kalnay, S.M., 2002, Expression of the receptor protein-tyrosine phosphatase, PTPmu, restores E-cadherindependent adhesion in human prostate carcinoma cells. J.Biol.Chem. 277: 11165–11173.
Chattopadhyay, N., Wang, Z., Ashman, L.K., Brady-Kalnay, S.M., and Kreidberg, J.A., 2003) alpha3beta1 integrin-CD151, a component of the cadherin-catenin complex, regulates PTPmu expression and cell-cell adhesion. J. Cell Biol. 163: 1351–1362.
Adams, C.L., Chen, Y.T., Smith, S.J., and Nelson, W.J., 1998, Mechanisms of epithelial cell-cell adhesion and cell compaction revealed by high-resolution tracking of Ecadheringreen fluorescent protein. J. Cell Biol. 142: 1105–1119.
Mo, Y.Y., Reynolds, A.B., 1996, Identification of murine p120 isoforms and heterogeneous expression of p120cas isoforms in human tumor cell lines. Cancer Res. 56: 2633–2640.
Aono, S., Nakagawa, S., Reynolds, A.B., and Takeichi, M., 1999, p120(ctn) acts as an inhibitory regulator of cadherin function in colon carcinoma cells. J. Cell Biol. 145: 551–562.
Berens, M.E., Rief, M.D., Loo, M.A., and Giese, A., 1994, The role of extracellular matrix in human astrocytoma migration and proliferation studied in a microliter scale assay. Clinical & Expt. Metastasis 12: 405–415.
Maeda, M., Johnson, K.R., and Wheelock, M.J., 2005, Cadherin switching: essential for behavioral but not morphological changes during an epithelium-to-mesenchyme transition. J.Cell Sci. 118: 873–887.
Williams, E.J., Williams, G., Howell, F.V., Skaper, S.D., Walsh, F.S., and Doherty, P. , 2001, Identification of an N-cadherin motif that can interact with the fibroblast growth factor receptor and is required for axonal growth. J. Biol. Chem. 276: 43879–43886.
Monier-Gavelle, F., Duband, J.L., 1997, Cross talk between adhesion molecules: control of N-cadherin activity by intracellular signals elicited by beta1 and beta3 integrins in migrating neural crest cells. J. Cell Biol. 137: 1663–1681.
Arregui, C., Pathre, P. , Lilien, J., and Balsamo, J., 2000, The nonreceptor tyrosine kinase fer mediates cross-talk between N-cadherin and beta1-integrins. J. Cell Biol. 149: 1263–1274.
Ojakian, G.K., Ratcliffe, D.R., and Schwimmer, R., 2001, Integrin regulation of cell-cell adhesion during epithelial tubule formation. J. Cell Science, 114: 941–952.
Frisch, S.M., Ruoslahti, E., 1997, Integrins and anoikis. Current Opinion in Cell Biology 9: 701–706.
Tran, N.L., Adams, D.G., Vallincourt, R.L., and Heimark, R.L., 2002, Signaling from N-cadherin increases Bcl-2: regulation of the Phosphatidylinositol 3-Kinase/Akt pathway by homophilic adhesion and actin cytoskeletal organization. J Biol. Chem. 277: 32905–32914.
Lambert, M., Choquet, D., and Mege, R.M., 2002, Dynamics of ligand-induced, Rac1-dependent anchoring of cadherins to the actin cytoskeleton. J. Cell Biol. 157: 469–479.
Majumder, P. K., Yeh, J.J., George, D.J., Febbo, P.G., Kum, J., Xue, Q., Bikoff, R., Ma, H., Kantoff, P.W., Golub, T.R., Loda, M., and Sellers, W.R., 2003, Prostate intraepithelial neoplasia induced by prostate restricted Akt activation: the MPAKT model. Proc. Natl. Acad. Sci. U.S.A 100: 7841–7846.
Kreisberg, J.I., Malik, S.N., Prihoda, T.J., Bedolla, R.G., Troyer, D.A., Kreisberg, S., and Ghosh, P.M., 2004, Phosphorylation of Akt (Ser473) is an excellent predictor of poor clinical outcome in prostate cancer. Cancer Res. 64: 5232–5236.
Apakama, I., Robinson, M.C., Walter, N.M., Charlton, R.G., Royds, J.A., Fuller, C.E., Neal, D.E., and Hamdy, F.C., 1996, bcl-2 overexpression combined with p53 protein accumulation correlates with hormone-refractory prostate cancer. British J. Cancer 74: 1258–1262.
Colombel, M., Symmans, F., Gil, S., O'Toole, K.M., Chopin, D., Benson, M., Olsson, C.A., Korsmeyer, S., and Buttyan, R., 1993, Detection of the apoptosis-suppressing oncoprotein bc1–2 in hormone-refractory human prostate cancers. American Journal of Pathology 143: 390–400.
McDonnell, T.J., Navone, N.M., Troncoso, P. , Pisters, L.L., Conti, C, von Eschenbach, A.C., Brisbay, S., and Logothetis, C.J., 1997, Expression of bcl-2 oncoprotein and p53 protein accumulation in bone marrow metastases of androgen independent prostate cancer. J. Urology 157: 569–574.
Bruckheimer, E.M., Cho, S., Brisbay, S., Johnson, D.J., Gingrich, J.R., Greenberg, N., and McDonnell, T.J., 2000, The impact of bcl-2 expression and bax deficiency on prostate homeostasis in vivo. Oncogene 19: 2404–2412.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer
About this chapter
Cite this chapter
Heimark, R.L., Alexander, N.R. (2006). REGULATION OF CADHERINS DURING PROSTATE CANCER PROGRESSION. In: Cress, A.E., Nagle, R.B. (eds) Cell Adhesion and Cytoskeletal Molecules in Metastasis. Cancer Metastasis – Biology and Treatment, vol 9. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-5129-6_3
Download citation
DOI: https://doi.org/10.1007/978-1-4020-5129-6_3
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-5128-9
Online ISBN: 978-1-4020-5129-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)